Cargando…
Comet assay measures of DNA damage as biomarkers of irinotecan response in colorectal cancer in vitro and in vivo
The use of irinotecan to treat metastatic colorectal cancer (CRC) is limited by unpredictable response and variable toxicity; however, no reliable clinical biomarkers are available. Here, we report a study to ascertain whether irinotecan-induced DNA damage measures are suitable/superior biomarkers o...
Autores principales: | Wood, Joanna P, Smith, Andrew J O, Bowman, Karen J, Thomas, Anne L, Jones, George D D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567016/ https://www.ncbi.nlm.nih.gov/pubmed/26108357 http://dx.doi.org/10.1002/cam4.477 |
Ejemplares similares
-
Introducing a true internal standard for the Comet assay to minimize intra- and inter-experiment variability in measures of DNA damage and repair
por: Zainol, Murizal, et al.
Publicado: (2009) -
Comet Assay Profiling of FLASH-Induced Damage: Mechanistic Insights into the Effects of FLASH Irradiation
por: Cooper, Christian R., et al.
Publicado: (2023) -
An ECVAG† trial on assessment of oxidative damage to DNA measured by the comet assay
por: Johansson, Clara, et al.
Publicado: (2010) -
B-Comet Assay (Comet Assay on Buccal Cells) for the Evaluation of Primary DNA Damage in Human Biomonitoring Studies
por: Russo, Carla, et al.
Publicado: (2020) -
The in vivo genotoxicity of isotretinoin assessed by comet assay
por: Bordbar, Maede, et al.
Publicado: (2020)